Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Benraad, T. h. J., Geurts-Moespot, A., Sala, M., Piffanelli, A. Ross, A. & Foekens, J. A. on behalf of the EORTC Receptor Study Group (1992). Quality control of cathespin D measurement by the EORTC Receptor Study Group. Eur J Cancer 28: 72–75.
2. Foekens, J. A., Berns, EMJJ, Look, M. P. & Klijn, J. G. M. (1996). Prognostic factors in node-negative breast cancer. In Hormone-Dependent Cancer, Pasqualini JR, Katzenellenbogen BS (eds), pp. 217–252, Marcel Dekker: New York
3. Foekens, J. A., Look, M. P., Bolt-deVries, J., Meijer-van Gelder, M. E., van Putten, W. L. J. & Klijn, J. G. M. (1998). Cathepsin D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer 79: 300–307.
4. Nadji, M., Fresno, M., Nassiri, M., Conner, G., Herrero, A. & Morales, A. R. (1996). Cathepsin D in host stromal cells, but not in tumour cells, is associated with aggressive behaviour in node-negative breast cancer. Hum Pathol 27: 890–895.
5. O’Donaghue, AEMA, Poller, D. N., Bell, J. A., Galea, M. H., Elston, C. W., Blamey, R. W. & Ellis, I. O. (1995). Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression in cathepsin D in stromal cells. Breast Cancer Res Treat 33: 137–145.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献